TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 97 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $15,000 | -96.2% | 254 | -94.3% | 0.01% | -74.4% |
| Q4 2019 | $392,000 | +111.9% | 4,461 | +81.3% | 0.04% | +116.7% |
| Q3 2019 | $185,000 | +270.0% | 2,461 | +312.9% | 0.02% | +260.0% |
| Q2 2019 | $50,000 | -15.3% | 596 | -1.0% | 0.01% | +25.0% |
| Q3 2018 | $59,000 | +18.0% | 602 | +37.4% | 0.00% | +33.3% |
| Q2 2018 | $50,000 | +19.0% | 438 | +2.6% | 0.00% | -25.0% |
| Q1 2018 | $42,000 | – | 427 | +42600.0% | 0.00% | – |
| Q1 2017 | $0 | -100.0% | 1 | -97.8% | 0.00% | – |
| Q4 2016 | $4,000 | -96.9% | 45 | -96.2% | 0.00% | -100.0% |
| Q3 2016 | $131,000 | +445.8% | 1,192 | +654.4% | 0.02% | +275.0% |
| Q4 2015 | $24,000 | -78.6% | 158 | -79.9% | 0.00% | -80.0% |
| Q3 2015 | $112,000 | -38.5% | 787 | -37.9% | 0.02% | -39.4% |
| Q2 2015 | $182,000 | +3.4% | 1,267 | +1.4% | 0.03% | -25.0% |
| Q1 2015 | $176,000 | +45.5% | 1,249 | +52.9% | 0.04% | +12.8% |
| Q4 2014 | $121,000 | – | 817 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |